HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Sprayable Hydrogel Protects Heart from Post-Surgical Adhesions

By HospiMedica International staff writers
Posted on 29 Jun 2021
Image: A spray-on gel isolates the heart from surrounding tissue to minimize adhesions (Photo courtesy of Getty Images)
Image: A spray-on gel isolates the heart from surrounding tissue to minimize adhesions (Photo courtesy of Getty Images)
A new study describes how a novel hydrogel binds to the heart muscle to form a soft, elastic barrier that protects it from adhesions following surgery.

Developed at the University of California, San Diego (UCSD; USA), the hydrogel barrier is comprised of aldehyde (ALD), aminooxy (AO), and oxime crosslinked poly(ethylene glycol) (PEG), functionalized with a catechol (CAT) group, that are mixed together to form the final gel (ALD-AO-CAT). The gel has favorable mechanical properties, degradation kinetics, minimal swelling, and superior tissue retention. The material is also cytocompatible, resists cell adhesion, and reduces the severity of adhesions. It can be easily removed from tissue and dissolves after four to six weeks.

The researchers also designed a device to safely and accurately spray the hydrogel inside the surgical field during open heart surgery. The spraying device houses the hydrogel's two main components in two different chambers; each is made of PEG with different reactive groups that crosslink together to form the hydrogel. One of the solutions also includes the catechol-modified PEG to ensure it stays on the heart. The two mix as they exit the device, forming the hydrogel. The researchers described the process as akin to using two cans of spray paint, for example blue and yellow, to create a third color, green. The study was published on June 18, 2021, in Nature Communications.

“We demonstrated here that the ALD–AO–CAT hydrogel possesses mechanical characteristics and degradation kinetics that are well-suited to the conditions within the chest cavity. The material also demonstrated a lower degree of swelling that surpasses the behavior of existing products,” said senior author Professor Karen Christman, PhD, and colleagues. “Our work is an engineering solution driven by a medical problem, and now it's poised to significantly improve cardiac surgery, both for adults and children.”

Depressed fibrinolytic activity resulting from surgical trauma to the epicardium during open-heart procedures can lead to fibrous adhesion formations between the epicardium and other tissues in the chest cavity. For children born with congenital heart defects, who will experience multiple surgeries over their lifetime, and adults receiving valve replacements, mechanical circulatory support, and/or coronary artery bypass grafting, this problem is particularly relevant, as these adhesions impede heart function and severely complicate resternotomy by obstructing visibility and increasing the risk of mortality and morbidity during dissection.

Related Links:
University of California, San Diego

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Half Apron
Demi
Mobile X-Ray System
K4W

Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more